|
|
|
|
you’re
in > Products > Agilent Technologies > BioAnalysis > MARS > LC Human 6
|
| |
Multiple Affinity Removal LC Column - Human 6
|
 |
Simple method removes 6 abundant proteins
The Multiple Affinity Removal LC Column – Human 6 is designed as a simple way to remove SIX interfering high-abundant proteins from human plasma samples. Removal of these abundant proteins improves the subsequent LC/MS and electrophoretic analysis of the serum sample by effectively expanding the dynamic range of the analysis. |
|
|
- Column eliminates approximately 85 - 90% of total protein (albumin, IgG, IgA, transferrin, haptoglobin, and antitrypsin) when used with the Multiple Affinity Removal System
- Three column dimensions include 4.6 x 50 mm, 4.6 x 100 mm, 10 x 100 mm
- Serum injection volume ranges between 15 - 80 µL per run for the 4.6 mm ID, and up to 340 µL for the 10 mm ID column
- Minimize sample loss by utilizing our rapid, single injection protocols and optimized buffers
Columns can last for over 200 injections
- Process the most plasma/serum over the column lifetime, up to 16,000 µL for the 4.6 mm ID columns and 68,000 µL for the 10 mm ID column
- Protocols and column are optimized for use with human serum. Column not recommended for use with mouse serum
- Column is compatible with most LC or HPLC pumps or instruments
|
| |
| For Starter Kit, Individual Reagents and Individual Accessories please click here |
| |
| Description |
Size (mm) |
Part Number |
| |
|
|
Multiple Affinity Removal Column, Hu-6
15 - 20 µL HUMAN serum capacity per injection |
4.6 x 50 |
5185-5984 |
Multiple Affinity Removal Column, Hu-6HC
30 - 40 µL HUMAN serum capacity per injection |
4.6 x 50 |
5188-5332 |
Multiple Affinity Removal Column, Hu-6
30 - 40 µL HUMAN serum capacity per injection |
4.6 x 100 |
5185-5985 |
Multiple Affinity Removal Column, Hu-6HC
60 - 80 µL HUMAN serum capacity per injection |
4.6 x 100 |
5188-5333 |
Multiple Affinity Removal Column, Hu-6HC
up 340 µL HUMAN serum capacity per injection. |
10 x 100 |
5188-5336 |
|
| |
| |
|
|
|
|
|
